Cinaclat 60 Tablet contains Cinacalcet 60 mg, a potent calcimimetic agent indicated for secondary hyperparathyroidism in chronic kidney disease (CKD) patients on dialysis and parathyroid carcinoma. It works by enhancing the sensitivity of calcium-sensing receptors on parathyroid glands, reducing PTH secretion, and effectively controlling serum calcium levels.
This higher-dose formulation is particularly useful for patients with persistent elevated PTH or hypercalcemia who require stronger control. Cinacalcet helps prevent bone disease, vascular calcification, and associated metabolic complications in CKD.
Clinically, Cinaclat 60 Tablet is indicated for secondary hyperparathyroidism, parathyroid carcinoma, and metabolic calcium-phosphate disorders, providing reliable therapeutic outcomes and improved patient management.
The tablet ensures precise dosing, convenient oral administration, and consistent clinical effect, making it suitable for hospital, dialysis, and long-term outpatient care.
Common side effects may include nausea, vomiting, hypocalcemia, dizziness, and headache. Rarely, severe hypocalcemia, muscle cramps, or allergic reactions may occur.
Cinaclat 60 Tablet contains Cinacalcet 60 mg, a potent calcimimetic agent indicated for secondary hyperparathyroidism in chronic kidney disease (CKD) patients on dialysis and parathyroid carcinoma. It works by enhancing the sensitivity of calcium-sensing receptors on parathyroid glands, reducing PTH secretion, and effectively controlling serum calcium levels. This higher-dose formulation is particularly useful for patients with persistent elevated PTH or hypercalcemia who require stronger control. Cinacalcet helps prevent bone disease, vascular calcification, and associated metabolic complications in CKD. Clinically, Cinaclat 60 Tablet is indicated for secondary hyperparathyroidism, parathyroid carcinoma, and metabolic calcium-phosphate disorders, providing reliable therapeutic outcomes and improved patient management. The tablet ensures precise dosing, convenient oral administration, and consistent clinical effect, making it suitable for hospital, dialysis, and long-term outpatient care.
Use Cinaclat 60 Tablet strictly under medical supervision. Regular monitoring of serum calcium, phosphate, and PTH levels is essential. Inform your doctor of any history of hypocalcemia, cardiac arrhythmias, or gastrointestinal disorders. Seek immediate medical attention if severe muscle cramps, numbness, or irregular heartbeat develops.
Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight. Keep out of reach of children. Do not use beyond the expiry date.